Entity type
Individual
CIK 0001340098. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.
Entity type
Individual
Total filings
30
Latest filing
14 May 2021
Industry
n/a
Filing-backed research brief
Latest signal: 13F-HR for Q1 2021. Each card links back to the PortfolioSavvy page where the filing evidence is closest.
Latest 13F portfolio
$25.37M
1 holdings for Q1 2021
Open portfolioLargest parsed holding
LXRX
$25.37M reported value
Open holding13D/G large stake
—
No recent parsed 13D/G stake row for this CIK.
Browse 13D/GInsider / owner context
—
No parsed Forms 3/4/5 owner position for this CIK.
Browse insider filingsSave this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
13F-HR filed on 14 May 2021 for CIK 0001340098.
These bars compare filing-backed value available in each disclosure family. Read them as separate lenses, not as one combined ownership total.
Quarterly institutional holdings reported on Form 13F.
Latest reported 13F value
13FReported market value from the latest parsed Form 13F information table; this is not total assets under management.
Largest 13F holdings
13FLargest symbols in the latest parsed Form 13F information table.
Largest symbols in the latest parsed Form 13F information table.
Filer intelligence
A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.
Counts show available parsed rows, not one combined ownership total.
Visual share of the latest parsed 13F portfolio. Values are reported market value, not a recommendation.
Top 5 concentration
100%
Share of latest parsed 13F value represented by the visible holdings below.
Top 5 reported value
$25.37M
Compared with $25.37M total 13F value.
Top 5 net change
$0
Position-value change inside the visible top holdings only.
A simple visual split of the latest parsed 13F portfolio.
Lexicon Pharmaceuticals Inc
$25.37M
Latest update
Latest 13F period: Q1 2021. Open the source-backed page to inspect the fresh filing or facts context.
Update date
14 May 2021
Page type
Filer profile
Latest period
Q1 2021
Institutional portfolio context was refreshed from a 13F filing filed on 14 May 2021.
SEC filing record
Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.
Observed form types
CIK-linked evidence first
Showing the latest 12 of 30 SEC filings for Ulys, L.L.C..